REPORT ID 2394

United States Self-monitoring Blood Glucose Devices Market Report 2017

Publish Date
8-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the United States Self-monitoring Blood Glucose Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Self-monitoring Blood Glucose Devices in these regions, from 2012 to 2022 (forecast).

United States Self-monitoring Blood Glucose Devices market competition by top manufacturers/players, with Self-monitoring Blood Glucose Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott
    AgaMatrix Inc
    ARKRAY
    B. Braun
    Bayer
    Hainice Medical
    Infopia
    I-SENS. Inc.
    Lifescan
    Nipro Dagnostics
    Omron
    Roche
    Terumo Corporation

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Strips
    Glucose Meters
    Lancets
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Home Care
    Hospitals

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Self-monitoring Blood Glucose Devices Market Report 2017
1 Self-monitoring Blood Glucose Devices Overview
    1.1 Product Overview and Scope of Self-monitoring Blood Glucose Devices
    1.2 Classification of Self-monitoring Blood Glucose Devices by Product Category
        1.2.1 United States Self-monitoring Blood Glucose Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Self-monitoring Blood Glucose Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Strips
        1.2.4 Glucose Meters
        1.2.5 Lancets
        1.2.6 Others
    1.3 United States Self-monitoring Blood Glucose Devices Market by Application/End Users
        1.3.1 United States Self-monitoring Blood Glucose Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Home Care
        1.3.3 Hospitals
    1.4 United States Self-monitoring Blood Glucose Devices Market by Region
        1.4.1 United States Self-monitoring Blood Glucose Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Self-monitoring Blood Glucose Devices Status and Prospect (2012-2022)
        1.4.3 Southwest Self-monitoring Blood Glucose Devices Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Self-monitoring Blood Glucose Devices Status and Prospect (2012-2022)
        1.4.5 New England Self-monitoring Blood Glucose Devices Status and Prospect (2012-2022)
        1.4.6 The South Self-monitoring Blood Glucose Devices Status and Prospect (2012-2022)
        1.4.7 The Midwest Self-monitoring Blood Glucose Devices Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Self-monitoring Blood Glucose Devices (2012-2022)
        1.5.1 United States Self-monitoring Blood Glucose Devices Sales and Growth Rate (2012-2022)
        1.5.2 United States Self-monitoring Blood Glucose Devices Revenue and Growth Rate (2012-2022)

2 United States Self-monitoring Blood Glucose Devices Market Competition by Players/Suppliers
    2.1 United States Self-monitoring Blood Glucose Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Self-monitoring Blood Glucose Devices Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Self-monitoring Blood Glucose Devices Average Price by Players/Suppliers (2012-2017)
    2.4 United States Self-monitoring Blood Glucose Devices Market Competitive Situation and Trends
        2.4.1 United States Self-monitoring Blood Glucose Devices Market Concentration Rate
        2.4.2 United States Self-monitoring Blood Glucose Devices Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Self-monitoring Blood Glucose Devices Manufacturing Base Distribution, Sales Area, Product Type

3 United States Self-monitoring Blood Glucose Devices Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Self-monitoring Blood Glucose Devices Sales and Market Share by Region (2012-2017)
    3.2 United States Self-monitoring Blood Glucose Devices Revenue and Market Share by Region (2012-2017)
    3.3 United States Self-monitoring Blood Glucose Devices Price by Region (2012-2017)

4 United States Self-monitoring Blood Glucose Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Self-monitoring Blood Glucose Devices Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Self-monitoring Blood Glucose Devices Revenue and Market Share by Type (2012-2017)
    4.3 United States Self-monitoring Blood Glucose Devices Price by Type (2012-2017)
    4.4 United States Self-monitoring Blood Glucose Devices Sales Growth Rate by Type (2012-2017)

5 United States Self-monitoring Blood Glucose Devices Sales (Volume) by Application (2012-2017)
    5.1 United States Self-monitoring Blood Glucose Devices Sales and Market Share by Application (2012-2017)
    5.2 United States Self-monitoring Blood Glucose Devices Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Self-monitoring Blood Glucose Devices Players/Suppliers Profiles and Sales Data
    6.1 Abbott
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 AgaMatrix Inc
        6.2.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 AgaMatrix Inc Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 ARKRAY
        6.3.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 ARKRAY Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 B. Braun
        6.4.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 B. Braun Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bayer
        6.5.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bayer Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Hainice Medical
        6.6.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Hainice Medical Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Infopia
        6.7.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Infopia Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 I-SENS. Inc.
        6.8.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 I-SENS. Inc. Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Lifescan
        6.9.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Lifescan Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Nipro Dagnostics
        6.10.2 Self-monitoring Blood Glucose Devices Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Nipro Dagnostics Self-monitoring Blood Glucose Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Omron
    6.12 Roche
    6.13 Terumo Corporation

7 Self-monitoring Blood Glucose Devices Manufacturing Cost Analysis
    7.1 Self-monitoring Blood Glucose Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Self-monitoring Blood Glucose Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Self-monitoring Blood Glucose Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Self-monitoring Blood Glucose Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Self-monitoring Blood Glucose Devices Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Self-monitoring Blood Glucose Devices Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Self-monitoring Blood Glucose Devices Sales Volume Forecast by Type (2017-2022)
    11.3 United States Self-monitoring Blood Glucose Devices Sales Volume Forecast by Application (2017-2022)
    11.4 United States Self-monitoring Blood Glucose Devices Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer